Stockreport

Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response (DDR) Cancer Therapeutics [Yahoo! Finance]

Aprea Therapeutics, Inc.  (APRE) 
PDF Wed, February 5, 2025 at 2:00 PM GMT+1 3 min read In This Article APRE Aprea Therapeutics DOYLESTOWN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutic [Read more]